Sodium Iodide → HCID 58137300, compound

HRID 1424640Notes

Reaction equation

[Br:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:28]=1[C:9]1([CH2:14][CH2:13][N:12]([C:15]([NH:17][CH:18]3[CH:25]4[CH2:26][CH:21]5[CH2:22][CH:23]([CH2:27][CH:19]3[CH2:20]5)[CH2:24]4)=[O:16])[CH2:11][CH2:10]1)[CH2:8][CH:7]2[CH2:29][CH2:30]OS(C1C=CC(C)=CC=1)(=O)=O.[C:42]([O-:45])([O-])=O.[K+].[K+].[Na+].[I-]>CC#N>[Br:1][C:2]1[CH:3]=[CH:4][CH:5]=[C:6]2[C:28]=1[C:9]1([CH2:14][CH2:13][N:12]([C:15]([NH:17][CH:18]3[CH:19]4[CH2:27][CH:23]5[CH2:22][CH:21]([CH2:26][CH:25]3[CH2:24]5)[CH2:20]4)=[O:16])[CH2:11][CH2:10]1)[CH2:8][CH:7]2[CH2:29][CH2:30][N:12]1[CH2:13][CH2:42][O:45][CH2:10][CH2:11]1

Participants

Conditions

Temperature: 85 °C

Procedure

To a solution of (±)-7-bromo-N-(2-adamantyl)-3-(2-(p-toluenesulfonyloxy)ethyl)-2,3-dihydrospiro[indene-1,4′-piperidine]-1′-carboxamide (50 mg, 0.078 mmol) and K2CO3 (21.56 mg, 0.156 mmol) in anhydrous CH3CN (3 mL) was added NaI (3 mg, 0.020 mmol) at 0° C. Then the mixture was stirred overnight at 80-90° C. The mixture was concentrated to give the crude product which was purified by preparative HPLC to afford (±)-7-bromo-N-(2-adamantyl)-3-(2-morpholinoethyl)-2,3-dihydrospiro[indene-1,4′-piperidine]-1′-carboxamide (4 mg, 9%). LC-MS Method 5 tR=1.09 min, m/z=558; 1H NMR: (400 MHz, CDCl3): δ=1.43 (m, 2H), 1.56-1.69 (m. 3H), 1.75-1.85 (m, 9H), 1.94-2.05 (m, 3H), 2.45-2.59 (m, 4H), 2.91 (m, 2H), 3.12 (m, 5H), 3.25 (m, 2H), 3.56 (m, 3H), 3.91-4.16 (m, 6H), 4.20 (m, 2H), 7.12 (m, 2H), 7.40 (m, 1H).

Workup

concentrationThe mixture was concentrated
customto give the crude product which
customwas purified by preparative HPLC

Sources & evidence

ORD record: ord-9d32522ba3ee4ce6b67f3a53f683f035
Source dataset: uspto-grants-2015_01
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08927715B2

Reaction notes

Loading…